Cargando…
Tissue‐specific tumor microenvironments influence responses to immunotherapies
OBJECTIVES: Investigation of variable response rates to cancer immunotherapies has exposed the immunosuppressive tumor microenvironment (TME) as a limiting factor of therapeutic efficacy. A determinant of TME composition is the tumor location, and clinical data have revealed associations between cer...
Autores principales: | Oliver, Amanda J, Davey, Ashleigh S, Keam, Simon P, Mardiana, Sherly, Chan, Jack D, von Scheidt, Bianca, Beavis, Paul A, House, Imran G, Van Audernaerde, Jonas RM, Darcy, Phillip K, Kershaw, Michael H, Slaney, Clare Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869967/ https://www.ncbi.nlm.nih.gov/pubmed/31768254 http://dx.doi.org/10.1002/cti2.1094 |
Ejemplares similares
-
Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
por: Oliver, Amanda J., et al.
Publicado: (2020) -
Switching on the green light for chimeric antigen receptor T‐cell therapy
por: Mardiana, Sherly, et al.
Publicado: (2019) -
Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
por: Oliver, Amanda J., et al.
Publicado: (2018) -
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
por: Oliver, Amanda J, et al.
Publicado: (2020) -
Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
por: Chan, Jack D, et al.
Publicado: (2020)